Morgan Stanley’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,300
| Closed | -$7.61K | – | 8329 |
|
|
2025
Q1 | $7.61K | Hold |
4,300
| – | – | ﹤0.01% | 6883 |
|
|
2024
Q4 | $9.89K | Sell |
4,300
-1,250
| -23% | -$2.88K | ﹤0.01% | 6804 |
|
|
2024
Q3 | $19.6K | Buy |
5,550
+4,300
| +344% | +$15.2K | ﹤0.01% | 6507 |
|
|
2024
Q2 | $3.46K | Hold |
1,250
| – | – | ﹤0.01% | 6947 |
|
|
2024
Q1 | $8.29K | Sell |
1,250
-1,250
| -50% | -$8.29K | ﹤0.01% | 6764 |
|
|
2023
Q4 | $7.62K | Buy |
2,500
+1,250
| +100% | +$3.81K | ﹤0.01% | 6896 |
|
|
2023
Q3 | $1.9K | Hold |
1,250
| – | – | ﹤0.01% | 7144 |
|
|
2023
Q2 | $2.24K | Hold |
1,250
| – | – | ﹤0.01% | 7174 |
|
|
2023
Q1 | $1.55K | Hold |
1,250
| – | – | ﹤0.01% | 7285 |
|
|
2022
Q4 | $2.96K | Sell |
1,250
-1
| -0.1% | -$2 | ﹤0.01% | 7270 |
|
|
2022
Q3 | $5K | Buy |
1,251
+1
| +0.1% | +$4 | ﹤0.01% | 7262 |
|
|
2022
Q2 | $7K | Sell |
1,250
-221
| -15% | -$1.24K | ﹤0.01% | 7334 |
|
|
2022
Q1 | $15K | Sell |
1,471
-33,415
| -96% | -$341K | ﹤0.01% | 7269 |
|
|
2021
Q4 | $393K | Buy |
34,886
+32,463
| +1,340% | +$366K | ﹤0.01% | 5692 |
|
|
2021
Q3 | $50K | Buy |
2,423
+537
| +28% | +$11.1K | ﹤0.01% | 6728 |
|
|
2021
Q2 | $47K | Buy |
1,886
+1,301
| +222% | +$32.4K | ﹤0.01% | 6699 |
|
|
2021
Q1 | $17K | Buy |
+585
| New | +$17K | ﹤0.01% | 6784 |
|
|
2019
Q3 | – | Sell |
-1,475
| Closed | -$21K | – | 6784 |
|
|
2019
Q2 | $21K | Sell |
1,475
-18,432
| -93% | -$262K | ﹤0.01% | 5921 |
|
|
2019
Q1 | $776K | Buy |
19,907
+561
| +3% | +$21.9K | ﹤0.01% | 4278 |
|
|
2018
Q4 | $325K | Sell |
19,346
-2,050
| -10% | -$34.4K | ﹤0.01% | 5057 |
|
|
2018
Q3 | $1.18M | Buy |
21,396
+20,344
| +1,934% | +$1.12M | ﹤0.01% | 4410 |
|
|
2018
Q2 | $114K | Buy |
1,052
+167
| +19% | +$18.1K | ﹤0.01% | 5708 |
|
|
2018
Q1 | $144K | Buy |
885
+478
| +117% | +$77.8K | ﹤0.01% | 5600 |
|
|
2017
Q4 | $86K | Buy |
407
+85
| +26% | +$18K | ﹤0.01% | 5679 |
|
|
2017
Q3 | $86K | Buy |
+322
| New | +$86K | ﹤0.01% | 5617 |
|